Anti-tumour activity of bisphosphonates in preclinical models of breast cancer-Reference-Cited by-同舟云学术

Anti-tumour activity of bisphosphonates in preclinical models of breast cancer

Published:2010-12 Issue:6 Volume:12 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Holen Ingunn,Coleman Robert E

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2769.pdf

Reference65 articles.

1. Clézardin P, Ebetino FH, Fournier PG: Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity. Cancer Res. 2005, 65: 4971-4974.

2. Roelofs AJ, Thompson K, Gordon S, Rogers MJ: Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res. 2006, 12: 6222s-6230s. 10.1158/1078-0432.CCR-06-0843.

3. Brown HK, Holen I: Anti-tumour effects of bisphosphonates - what have we learned from in vivo models?. Curr Cancer Drug Targets. 2009, 9: 807-823. 10.2174/156800909789760339.

4. Santini D, Caraglia M, Vincenzi B, Holen I, Scarpa S, Budillon A, Tonini G: Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonates. Nat Clin Pract Oncol. 2006, 3: 325-338. 10.1038/ncponc0520.

5. AZURE, does Adjuvant Zoledronic acid redUce REcurrence in patients with high-risk, localized breast cancer?. Trial Protocol. 2005, 3-57. (ISRCTN79831382)

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Understanding the Hide-and-Seek Strategy of Hibernating Breast Cancer Cells and Their Implications in Oncology from a Broader Perspective: A Comprehensive Overview;Current Issues in Molecular Biology;2024-08-01

2. Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer;Pharmaceutics;2024-06-27

3. Drug Repositioning for Ovarian Cancer Treatment: An Update;Anti-Cancer Agents in Medicinal Chemistry;2024-05

4. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the Treatment of Malignant Tumor Bone Metastases;BioMed Research International;2022-11-16

5. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors;Breast Cancer;2022-11-01